Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FatPostRéa: Neuromuscular Function in ICU Survivors
NCT03849326Withdrawn
- Sponsor
- CHU Saint-Etienne
- Start
- Dec 2023
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: voluntary maximum force reduction at 2 weeks. Planned start Dec 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT03849326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849326.